10-K: Performant Financial Corporation Details Common Stock and Financial Performance in 10-K Filing

Sentiment:

Annual Results


Performant Financial Corporation's 10-K filing outlines the details of their common stock, business operations, and financial results for the year ended December 31, 2023.

Worse than expectedThe company reported a net loss of $7.5 million for the year ended December 31, 2023, which is worse than the $6.5 million net loss reported in the previous year.

Summary

  • Performant Financial Corporation has one class of securities registered under Section 12 of the Securities Exchange Act of 1934: their Common Stock.
  • The company's authorized capital stock consists of 500,000,000 shares of common stock and 50,000,000 shares of preferred stock, both with a par value of $0.0001 per share.
  • Holders of common stock are entitled to one vote per share for the election of directors and on all matters submitted to a vote of stockholders.
  • The company generated approximately $113.7 million in revenues, $7.5 million in net loss, $3.4 million in adjusted EBITDA, and $3.8 million in adjusted net loss for the year ended December 31, 2023.
  • The healthcare industry represents a significant portion of the U.S. GDP, with spending projected to reach nearly $7.2 trillion by 2031.
  • The company's revenue model is generally success-based, earning fees based on the amount of funds they enable clients to recover.
  • In 2023, the company generated approximately $117,000 of revenue per employee, compared to $110,000 in 2022.
  • The company has a multi-pronged growth strategy for the healthcare market, divided amongst national, mid-tier and smaller health plans.
  • The company's technology platform is designed to manage and store large amounts of data, including public, proprietary, and client-specific information.
  • The company has three Recovery Audit Contractor (RAC) contracts with CMS, covering Medicare payments in various regions.
  • The company also has a national exclusive Medicare Secondary Payer (MSP) contract with CMS.
  • The company's shares of common stock are listed on the NASDAQ Global Select Market under the symbol PFMT.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there are positives such as revenue growth and long-standing client relationships, the net loss and competitive pressures temper the overall sentiment. The company is navigating a complex market with both opportunities and challenges.

Positives

  • The company's revenue per employee increased year-over-year, indicating improved efficiency.
  • The company has long-standing client relationships, particularly with CMS, which spans over fifteen years.
  • The company's technology platform is scalable and flexible, allowing for deployment across multiple markets and processes.
  • The company has strong data and analytics capabilities, enabling them to achieve high audit results and recovery rates.
  • The company has a proven and experienced management team with significant industry expertise.
  • The company is expanding its payment integrity services in the healthcare market, which is expected to grow significantly.
  • The company's culture of innovation and client service philosophy enables continuous improvement and expanded value creation.

Negatives

  • The company reported a net loss of $7.5 million for the year ended December 31, 2023.
  • The company's customer care/outsourced services revenue decreased by 49% compared to the previous year.
  • The company faces significant competition in all aspects of its business.
  • The company's contracts are often not exclusive and do not commit clients to specific volumes of business.
  • The company's revenues are heavily reliant on a limited number of large clients.
  • The company's indebtedness could adversely affect its business and financial condition.
  • The company's business is subject to various risks and uncertainties, including those related to technology, privacy, and intellectual property.

Risks

  • The company faces a long implementation period for new contracts, which may cause expenses before revenue is received.
  • The company's revenues are heavily concentrated with a few large clients, and the loss of any of these clients could significantly impact revenue.
  • The company's contracts are often not exclusive and do not guarantee specific volumes of business.
  • The company faces significant competition in the markets it operates in.
  • The company's ability to derive revenue depends on the number and types of claims they are allowed to audit.
  • The company's indebtedness could adversely affect its business and financial condition.
  • The company's business is subject to risks related to technology failures, cybersecurity breaches, and intellectual property infringement.
  • The company's business is subject to extensive regulations, and failure to comply could result in liabilities and expenses.
  • The company's stock price could be volatile and influenced by various factors.
  • The company's significant stockholders have the ability to influence corporate activities.

Future Outlook

The company anticipates that its healthcare revenues will drive the majority of its overall revenue growth and expects the need for its offerings to increase in both public and private healthcare markets.

Management Comments

  • The management team, led by Simeon Kohl, has successfully grown the company's revenue base and service offerings, including the transition from the student loan market into healthcare.
  • The company believes its business platforms are adaptable to new markets and processes and service offerings within existing markets.
  • The company endeavors to automate and optimize what traditionally have been manually intensive processes in order to drive higher workforce productivity.

Industry Context

The healthcare industry represents a significant portion of the U.S. GDP, with spending projected to reach nearly $7.2 trillion by 2031, indicating a large market opportunity for Performant's services. The company's focus on payment integrity aligns with the industry's need to identify and recover improper payments.

Comparison to Industry Standards

  • The document mentions competitors such as Cotiviti, Inc. and HMS Holdings, a subsidiary of Gainwell Technologies LLC, which are also major players in the healthcare payment integrity market.
  • The company's success-based revenue model is common in the industry, where providers are often paid a percentage of the funds they recover for their clients.
  • The company's focus on technology-enabled services and data analytics is consistent with industry trends towards automation and efficiency.
  • The company's long-standing relationships with government agencies like CMS are a key differentiator, as these contracts are often difficult to obtain and maintain.
  • The company's expansion into the commercial healthcare market is a common strategy for payment integrity providers, as this market also presents significant opportunities for growth.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Anti-Takeover ProvisionsThe Certificate of Incorporation and Bylaws contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of Performant.N/AThese provisions are expected to discourage certain types of coercive takeover practices and inadequate takeover bids.
Classified BoardThe board of directors is divided into three classes, with approximately one-third of the board elected each year.N/AThis facilitates continuity and stability but could make replacing incumbent directors more difficult.
Director RemovalDirectors may be removed only for cause.N/AThis provision makes it more difficult for shareholders to remove directors.
Stockholder ActionStockholder action can only be taken at an annual or special meeting and not by written consent.N/AThis limits the ability of stockholders to take action outside of formal meetings.
Special MeetingsSpecial meetings can only be called by a majority of the board or holders of 50% or more of outstanding shares.N/AThis limits the ability of stockholders to call special meetings.
Advance Notice ProceduresThe Bylaws require an advance notice procedure for stockholder proposals and nominations.N/AThis may preclude certain business at a meeting if proper procedures are not followed.
Super Majority ApprovalAmendments to the Bylaws or specified provisions of the Certificate of Incorporation require a 66 2/3% vote.N/AThis could enable a minority of stockholders to exercise veto power over amendments.
Authorized but Unissued SharesThe company has authorized but unissued shares of common and preferred stock available for future issuance without stockholder approval.N/AThis could make it more difficult to obtain control of the company.
Business CombinationsThe company has elected not to be subject to Section 203 of the DGCL, but the Certificate of Incorporation contains similar provisions.N/AThis restricts business combinations with interested stockholders for a period of three years.

Legal Proceedings

  • The company is involved in various legal proceedings that arise from normal business operations from time to time.
  • The company does not expect any current legal proceedings to have a material adverse impact on its business or financial condition.

Stakeholder Impact

  • Shareholders may be impacted by the company's financial performance and stock price volatility.
  • Employees may be impacted by changes in the company's operations and growth strategy.
  • Customers may be impacted by the company's ability to provide effective payment integrity services.
  • Suppliers may be impacted by the company's financial stability and ability to pay for services.
  • Creditors may be impacted by the company's ability to meet its debt obligations.

Next Steps

  • The company intends to expand its payment integrity services in the healthcare market.
  • The company may consider strategic alliances or acquisitions to enhance its capabilities and enter new markets.
  • The company will continue to enhance its platforms through investments in new data and analytics capabilities.

Key Dates

DateDescription
2003-10-08Original Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware under the name DCS Holdings, Inc.
2012-08-15Third Amended and Restated Certificate of Incorporation of the Registrant, effective as of this date.
2021-03The company was re-awarded the CMS Region 1 contract with a term of eight-and-a-half years.
2022-11The company was awarded the RAC contract to audit improper payments for claims made under Medicare Parts A and B in Region 2.
2022-12The company was re-awarded the national exclusive MSP contract by CMS.
2023-03The company commenced operations under the re-awarded MSP contract.
2023-10-27The company entered into a new credit agreement with Wells Fargo Bank, National Association.
2023-12-31Fiscal year end.
2024-03-12As of this date, 76,920,460 shares of the registrants common stock were outstanding.
2024-03-13Date of the independent auditor's report.

Keywords

healthcare, payment integrity, claims auditing, recovery, Medicare, CMS, technology platform, data analytics, improper payments, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.